InspireMD (NSPR) Price to Sales (2011 - 2026)

InspireMD has reported Price to Sales for 16 years, with the latest figure at 33.46 in Q2 2026.

• On a quarterly basis, Price to Sales fell 48.61% year-over-year to 33.46 in Q2 2026; TTM through Jun 2026 was 5.47, a 66.64% decrease from a year earlier, with the FY2025 full-year figure at 12.75, down 18.95% from the prior year.
• Price to Sales was 33.46 for Q2 2026 at InspireMD, down from 40.2 in the prior quarter.
• The five-year high for Price to Sales was 87.95 in Q1 2025, with the low at 6.98 in Q4 2022.
• Average Price to Sales over 5 years is 42.33, with a median of 38.28 recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Price to Sales sank 71.76% in 2022, then surged 728.45% in 2023.
• Over 5 years, Price to Sales stood at 6.98 in 2022, then surged by 399.09% to 34.85 in 2023, then surged by 62.34% to 56.58 in 2024, then tumbled by 35.73% to 36.36 in 2025, then slipped by 7.97% to 33.46 in 2026.
• The last three Price to Sales figures came in at 33.46 (Q2 2026), 40.2 (Q1 2026), and 36.36 (Q4 2025), per Business Quant data.